Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study.

Paul NL, Koton S, Simoni M, Geraghty OC, Luengo-Fernandez R, Rothwell PM.

J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):356-61. doi: 10.1136/jnnp-2012-303585. Epub 2012 Nov 20.

2.

Transient ischaemic attacks clinics provide equivalent and more efficient care than early in-hospital assessment.

Martínez-Martínez MM, Martínez-Sánchez P, Fuentes B, Cazorla-García R, Ruiz-Ares G, Correas-Callero E, Lara-Lara M, Díez-Tejedor E.

Eur J Neurol. 2013 Feb;20(2):338-43. doi: 10.1111/j.1468-1331.2012.03858.x. Epub 2012 Aug 29.

PMID:
22928874
3.

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison.

Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, Lovelock CE, Binney LE, Bull LM, Cuthbertson FC, Welch SJ, Bosch S, Alexander FC, Silver LE, Gutnikov SA, Mehta Z; Early use of Existing Preventive Strategies for Stroke (EXPRESS) study.

Lancet. 2007 Oct 20;370(9596):1432-42. Erratum in: Lancet. 2008 Feb 2;371(9610):386. Carasco-Alexander, Faye [corrected to Alexander, Faye C].

PMID:
17928046
4.

Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.

Luengo-Fernandez R, Gray AM, Rothwell PM.

Lancet Neurol. 2009 Mar;8(3):235-43. doi: 10.1016/S1474-4422(09)70019-5. Epub 2009 Feb 4.

5.

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.

Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B, Mehta Z.

Lancet. 2016 Jul 23;388(10042):365-375. doi: 10.1016/S0140-6736(16)30468-8. Epub 2016 May 18.

6.

Is the outpatient management of acute minor stroke feasible and safe?

Csiba L.

J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):243. doi: 10.1136/jnnp-2012-304141. Epub 2013 Jan 18. No abstract available.

PMID:
23334524
7.

Management of patients with transient ischemic attack is safe in an outpatient clinic based on rapid diagnosis and risk stratification.

Hörer S, Schulte-Altedorneburg G, Haberl RL.

Cerebrovasc Dis. 2011;32(5):504-10. doi: 10.1159/000331919. Epub 2011 Nov 4.

PMID:
22067086
8.

Long-Term Effect of Participation in an Early Exercise and Education Program on Clinical Outcomes and Cost Implications, in Patients with TIA and Minor, Non-Disabling Stroke.

Faulkner J, Stoner L, Lanford J, Jolliffe E, Mitchelmore A, Lambrick D.

Transl Stroke Res. 2017 Jun;8(3):220-227. doi: 10.1007/s12975-016-0510-6. Epub 2016 Nov 14.

PMID:
27844274
9.

Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.

Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU.

Cerebrovasc Dis. 2008;26(2):171-7. doi: 10.1159/000145324. Epub 2008 Jul 15.

PMID:
18628615
10.

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects.

Lavallée PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Lesèche G, Labreuche J, Touboul PJ, Amarenco P.

Lancet Neurol. 2007 Nov;6(11):953-60.

PMID:
17928270
11.

One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry.

Tan Y, Pan Y, Liu L, Wang Y, Zhao X, Wang Y; CNSR Investigators.

Neurol Res. 2017 Jun;39(6):484-491. doi: 10.1080/01616412.2017.1322804. Epub 2017 May 5.

PMID:
28476094
12.

ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack.

Chandratheva A, Geraghty OC, Luengo-Fernandez R, Rothwell PM; Oxford Vascular Study.

Stroke. 2010 May;41(5):851-6. doi: 10.1161/STROKEAHA.109.570010. Epub 2010 Mar 18.

13.

RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.

Edwards D, Fletcher K, Deller R, McManus R, Lasserson D, Giles M, Sims D, Norrie J, McGuire G, Cohn S, Whittle F, Hobbs V, Weir C, Mant J.

Trials. 2013 Jul 2;14:194. doi: 10.1186/1745-6215-14-194.

14.

Acute Ischemic Stroke (AIS) patient management in French stroke units and impact estimation of thrombolysis on care pathways and associated costs.

Schmidt A, Heroum C, Caumette D, Le Lay K, Bénard S.

Cerebrovasc Dis. 2015;39(2):94-101. doi: 10.1159/000369525. Epub 2015 Jan 23.

15.

Association between hospitalization and care after transient ischemic attack or minor stroke.

Kapral MK, Hall R, Fang J, Austin PC, Silver FL, Gladstone DJ, Casaubon LK, Stamplecoski M, Tu JV.

Neurology. 2016 Apr 26;86(17):1582-9. doi: 10.1212/WNL.0000000000002614. Epub 2016 Mar 25.

16.

Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke.

Webster F, Saposnik G, Kapral MK, Fang J, O'Callaghan C, Hachinski V.

Stroke. 2011 Nov;42(11):3176-82. doi: 10.1161/STROKEAHA.111.621524. Epub 2011 Sep 15.

17.

One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.

Burton TM, Lacey M, Liu F, Yu Y, Monsalvo ML, Lang K, Sander S.

J Med Econ. 2012;15(6):1217-25. doi: 10.3111/13696998.2012.718020. Epub 2012 Aug 17.

PMID:
22857539
18.

Addressing shortfalls in TIA care in the UK: an economic perspective.

Jackson D, Moshinsky J, Begg AJ.

J Med Econ. 2009;12(4):331-8. doi: 10.3111/13696990903365000.

PMID:
19835525
19.

Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.

Sluggett JK, Caughey GE, Ward MB, Gilbert AL.

Int J Clin Pharm. 2015 Oct;37(5):782-9. doi: 10.1007/s11096-015-0115-2. Epub 2015 Apr 29.

PMID:
25920907
20.

The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.

Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ.

J Manag Care Pharm. 2013 May;19(4):302-16.

Supplemental Content

Support Center